Monthly Archives: August 2009

Investor Perception Study Predicts Future of Biotech Sector

The BIO/Thomson Reuters Investor Perception Study is an in-depth assessment of Wall Street’s views of the biotech industry, its current challenges, its relative valuation, and the outlook for 2009. The analysis aims to provide BIO members with an insider’s perspective on what the investment community values in the current economic climate and help foster more effective communication between company management, shareholders, and potential investors.

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

India Threatens European Union: ‘Don’t Stop Flow of Illegal Drugs’

India’s Commerce Ministry drew attention to the “plight” of producers of infringing copies of vaccines last week, highlighting a need to quell the dangers of swine flu, whose vaccine is in legal hyper-production and distribution as we speak.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Sharing & Promoting Innovative Technology in Public-Private Global Development Partnerships

This year, CropLife International is assembling a diverse panel with substantial experience to offer their views on innovative solutions to critical global agricultural problems on Tuesday, September 29 (16:30-18:30) in Geneva.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Perfect Storm or Opportunity? Creating Global Food Security and Public Health Benefits Requires Food and Agricultural Research

Research on agriculture and food production is one of the foundations of modern society. According to one of my colleagues, it’s a proven fact that people who eat food live longer than people who do not. Just about everyone knows that a balanced diet can lead to better health. In the United States, we take our food – and all those benefits – for granted. We expect that our food will be easily available, safe, Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Urges Supreme Court to Reject Rigid Bilski Rule

In an amicus brief filed today, BIO urged the Supreme Court to overturn the decision of the U.S. Court of Appeals for the Federal Circuit in Bilski v. Doll.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,